Alluvi tirzepatide has been emerged as a promising therapeutic candidate for the control of metabolic diseases. This exploratory evaluation investigated the efficacy and tolerability of tirzepatide 40mg in experimental models of type 2 diabetes. The experiments demonstrated that tirzepatide 40mg substantially improved glycemic control and reduced i